Pfizer began trials of an updated vaccine targeting Omicron subvariants, The Financial Times reports.

Pfizer began trials of an updated vaccine targeting Omicron subvariants, The Financial Times reports.

| Tuesday 09 August 2022

More News

Top News

Exclusive